Shekeab Jauhari, MD
Associate Director, Drug Development, Sarah Cannon Research Institute at Florida Cancer Specialists - Lake Mary
Dr. Shekeab Jauhari serves as the associate director of drug development for Sarah Cannon Research Institute at Florida Cancer Specialists. He leads phase 1 clinical trials at the Lake Mary drug development unit (DDU), which opened in Lake Mary, Fla, in early 2020.
Dr. Jauhari earned his medical degree from the University of Miami Miller School of Medicine. He completed his internship and residency in internal medicine at the Hospital of the University of Pennsylvania, followed by fellowship training in hematology-oncology at Duke University.
During his fellowship, he was involved in the design and conduct of phase I clinical trials, selected to participate in the American Society of Hematology (ASH) Clinical Research Training Institute, and received a Conquer Cancer Foundation Young Investigator Award. He’s authored numerous publications relevant to hematologic malignancies, immune-based treatment approaches and early-phase oncology clinical trials.